Atlantic Union Bankshares’s iBio IBIO Stock Holding History

Atlantic Union Bankshares’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14	Closed	-$11	–	1669
2025 Q2	$11	Buy	+14	New	+$15	﹤0.01%	1224

Other funds holding IBIO

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Atlantic Union Bankshares's IBIO Position: Q3 2025 in Review

Atlantic Union Bankshares sold out of iBio (IBIO) in Q3 2025, closing a stake of 14 shares — an estimated $11 sold.

Atlantic Union Bankshares first reported a position in IBIO in Q2 2025 and held it in 1 quarter. The position peaked at $11 in Q2 2025. 32 funds tracked by Wall St. Rank hold IBIO as of Q3 2025.

Atlantic Union Bankshares reported no remaining iBio position as of Q3 2025 after selling out during the quarter.
Atlantic Union Bankshares sold 14 iBio shares in Q3 2025, an estimated $11.
Atlantic Union Bankshares first reported a position in iBio in Q2 2025 and held it in 1 quarter.
Atlantic Union Bankshares's iBio position peaked at $11 in Q2 2025.
32 funds tracked by Wall St. Rank held iBio as of Q3 2025.

Based on Atlantic Union Bankshares's 13F filing for Q3 2025, filed 4 Nov 2025.